🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/02/2006 51,66 51,90 48,00 49,02 -4,56% 7,55% 548.600
06/02/2006 51,84 55,20 50,70 51,36 +1,78% 8,68% 1.048.883
03/02/2006 51,60 52,14 49,62 50,46 -2,77% 4,88% 318.883
02/02/2006 50,52 52,20 48,90 51,90 +3,35% 6,53% 441.317
01/02/2006 52,08 53,58 49,44 50,22 -1,76% 7,95% 774.200
31/01/2006 46,08 51,12 45,00 51,12 +11,37% 13,28% 1.090.033
30/01/2006 45,84 47,82 44,22 45,90 -0,78% 7,85% 404.550
27/01/2006 45,78 47,70 45,30 46,26 +4,90% 5,24% 1.106.333
26/01/2006 44,28 44,58 42,42 44,10 -0,81% 4,88% 384.933
25/01/2006 46,74 47,10 43,08 44,46 -5,36% 8,60% 536.433
24/01/2006 46,68 48,18 42,24 46,98 +1,56% 12,72% 1.467.817
23/01/2006 46,50 49,26 45,54 46,26 +1,72% 8,00% 1.746.050
20/01/2006 38,40 53,28 38,34 45,48 +28,69% 38,91% 7.091.283
19/01/2006 35,58 36,30 34,26 35,34 -0,17% 5,73% 213.833
18/01/2006 36,00 36,00 32,46 35,40 -2,16% 9,83% 600.700
17/01/2006 33,30 37,98 33,12 36,18 +12,08% 14,59% 1.107.367
13/01/2006 28,74 32,82 28,50 32,28 +16,45% 15,03% 1.217.800
12/01/2006 27,06 28,86 26,46 27,72 +2,44% 8,87% 353.800
11/01/2006 26,94 27,30 25,74 27,06 +0,22% 5,79% 306.783
10/01/2006 25,50 27,00 25,32 27,00 +11,11% 6,59% 462.767
09/01/2006 24,66 25,02 23,64 24,30 -0,98% 5,60% 150.583
06/01/2006 22,14 25,44 21,72 24,54 +12,98% 16,80% 471.317
05/01/2006 22,08 22,26 21,60 21,72 -0,55% 2,99% 57.450
04/01/2006 21,66 22,08 20,94 21,84 +7,37% 5,26% 169.783
03/01/2006 20,52 20,70 19,56 20,34 -1,74% 5,56% 108.700
30/12/2005 20,88 20,94 20,34 20,70 -1,15% 2,87% 55.550
29/12/2005 21,18 21,42 20,70 20,94 -1,41% 3,40% 46.267
28/12/2005 21,66 21,72 20,40 21,24 -1,94% 6,09% 86.033
27/12/2005 22,02 22,44 21,66 21,66 -2,17% 3,54% 31.267
23/12/2005 21,78 22,32 21,66 22,14 +2,22% 3,03% 33.767